Media Statements Year None20212020201920182017 May 17 Regeneron Resumes Enrollment of FL and DLBCL Patients in Odronextamab Trials 164.6 KB Regeneron Resumes Enrollment of FL and DLBCL Patients in Odronextamab Trials 164.6 KB Apr 9 Regeneron Statement on Novartis Withdrawing Anti-VEGF Pre-Filled Syringe Case in the International Trade Commission 127.1 KB Regeneron Statement on Novartis Withdrawing Anti-VEGF Pre-Filled Syringe Case in the International Trade Commission 127.1 KB Feb 1 EMA Commences Rolling Review of Regeneron’s COVID-19 Antibody Cocktail 336.8 KB EMA Commences Rolling Review of Regeneron’s COVID-19 Antibody Cocktail 336.8 KB Jan 2 Regeneron Statement on Preliminary Injunction of the Most Favored Nation Rule 124.4 KB Regeneron Statement on Preliminary Injunction of the Most Favored Nation Rule 124.4 KB
Regeneron Statement on Novartis Withdrawing Anti-VEGF Pre-Filled Syringe Case in the International Trade Commission 127.1 KB
Regeneron Statement on Novartis Withdrawing Anti-VEGF Pre-Filled Syringe Case in the International Trade Commission 127.1 KB